A large population-based randomized controlled trial to increase attendance at screening for cervical cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 3, 2004, Pages 346-354

  Eaker, Sonja ^a   Adami, Hans Olov ^a,b   Granath, Fredrik ^a   Wilander, Erik ^c   Sparén, Pär ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b HARVARD UNIVERSITY   (United States)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER SCREENING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASS SCREENING; PAPANICOLAOU TEST; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMINDER SYSTEM; SWEDEN; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATIENT EDUCATION; TELEPHONE; UTERINE CERVIX TUMOR; UTILIZATION REVIEW; VAGINA SMEAR;

ADULT; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION; REMINDER SYSTEMS; SWEDEN; TELEPHONE; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 2442693167     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Ries LAG, Kosary CL, Hankey BF, et al. SEER cancer statistics review, 1973-1996. Bethesda (MD): National Cancer Institute; 1999.
2. Vizcaino AP, Moreno V, Bosch FX, et al. International trends in incidence of cervical cancer. II. Squamous-cell carcinoma. Int J Cancer, 2000;86:429-35.
3. Gustafsson L, Adami HO. Cytologic screening for cancer of the uterine cervix in Sweden evaluated by identification and simulation. Br J Cancer, 1990;61:903-8.
4. Bergstrom R, Sparen P, Adami HO. Trends in cancer of the cervix uteri in Sweden following cytological screening. Br J Cancer, 1999;81:159-66.
5. IARC Working Group on Evaluation of Cervical Cancer Screening Programmes. Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. Br Med J (Clin Res Ed), 1986;293:659-64.
6. Gustafsson L, Adami HO. Optimization of cervical cancer screening. Cancer Causes Control, 1992;3:125-36.
7. Elkind AK, Haran D, Eardley A, Spencer B. Reasons for non-attendance for computer-managed cervical screening: pilot interviews. Soc Sci Med, 1988;27:651-60.
8. Hill D, Gardner G, Rassaby J. Factors predisposing women to take precautions against breast and cervical cancer. J Appl Soc Psychol, 1985;15:59-79.
9. Peters RK, Bear MB, Thomas D. Barriers to screening for cancer of the cervix. Prev Med, 1989;18:133-46.
10. Murray M, McMillan C. Health beliefs, locus of control, emotional control and women's cancer screening behavior. Br J Clin Psychol, 1993;32:87-100.
11. Orbell S. Cognition and affect after cervical screening: the role of previous test outcome and personal obligation in future uptake expectations. Soc Sci Med, 1996;43:1237-43.
12. Lantz PM, Weigers ME, House JS. Education and income differentials in breast and cervical cancer screening. Policy implications for rural women. Med Care, 1997;35:219-36.
13. Eaker S, Adami HO, Sparen P. Attitudes to screening for cervical cancer: a population-based study in Sweden. Cancer Causes Control, 2001;12:519-28.
14. King J. Women's attitudes towards cervical smear. Update, 1987;Jan:160-8.
15. Hesselius I, Lisper HO, Nordstrom A, Anshelm-Olson B, Odlund B. Comparison between participants and non-participants at a gynecological mass screening. Scand J Soc Med, 1975;3:129-38.
16. Nicoll PM, Narayan KV, Paterson JG. Cervical cancer screening: women's knowledge, attitudes and preferences. Health Bull (Edinb), 1991;49:184-90.
17. Eaker S, Adami HO, Sparen P. Reasons women do not attend screening for cervical cancer: a population-based study in Sweden. Prev Med, 2001;32:482-91.
18. Selvin E, Brett KM. Breast and cervical cancer screening: sociodemographic predictors among White, Black, and Hispanic women. Am J Public Health, 2003;93:618-23.
19. Mandelblatt JS, Gold K, O'Malley AS, et al. Breast and cervix cancer screening among multiethnic women: role of age, health, and source of care. Prev Med, 1999;28:418-25.
20. Bergmann JB, Sigurdsson JA, Sigurdsson K. What attendance rate can be achieved for Pap smear screening? A case-control study of the characteristics of non-attenders and results of reminder efforts. Scand J Prim Health Care, 1996;14:152-8.
21. Orbell S, Crombie I, Robertson A, Johnston G, Kenicer M. Assessing the effectiveness of a screening campaign: who is missed by 80% cervical screening coverage? J R Soc Med, 1995;88:389-94.
22. Katz SJ, Hofer TP. Socioeconomic disparities in preventive care persist despite universal coverage. Breast and cervical cancer screening in Ontario and the United States. JAMA, 1994;272:530-4.
23. Harlan LC, Bernstein AB, Kessler LG. Cervical cancer screening: who is not screened and why? Am J Public Health, 1991;81:885-90.
24. Hewitt M, Devesa S, Breen N. Papanicolaou test use among reproductive-age women at high risk for cervical cancer: analyses of the 1995 National Survey of Family Growth. Am J Public Health, 2002;92:666-9.
25. Segnan N. Socioeconomic status and cancer screening. IARC Sci Publ, 1997;138:369-76.
26. Maxwell CJ, Bancej CM, Snider J, Vik SA. Factors important in promoting cervical cancer screening among Canadian women: findings from the 1996-97 National Population Health Survey (NPHS). Can J Public Health, 2001;92:127-33.
27. Mitchell H, Hirst S, Cockburn J, Reading DJ, Staples MP, Medley G. Cervical cancer screening: a comparison of recruitment strategies among older women. Med J Aust, 1991;155:79-82.
28. Mandelblatt J, Traxler M, Lakin P, et al. A nurse practitioner intervention to increase breast and cervical cancer screening for poor, elderly black women. The Harlem Study Team. J Gen Intern Med, 1993;8:173-8.
29. White JE, Begg L, Fishman NW, Guthrie B, Fagan JK. Increasing cervical cancer screening among minority elderly. Education and on-site services increase screening. J Gerontol Nurs, 1993;19:28-34.
30. Ansell D, Lacey L, Whitman S, Chen E, Phillips C. A nurse-delivered intervention to reduce barriers to breast and cervical cancer screening in Chicago inner city clinics. Public Health Rep, 1994;109:104-11.
31. Bowman J, Sanson-Fisher R, Boyle C, Pope S, Redman S. A randomized controlled trial of strategies to prompt attendance for a Pap smear. J Med Screen, 1995;2:211-8.
32. Lantz PM, Stencil D, Lippert MT, Beversdorf S, Jaros L, Remington PL. Breast and cervical cancer screening in a low-income managed care sample: the efficacy of physician letters and phone cells. Am J Public Health, 1995;85:834-6.
33. Dignan M, Michielutte R, Blinson K, et al. Effectiveness of health education to increase screening for cervical cancer among eastern-band Cherokee Indian women in North Carolina. J Natl Cancer Inst, 1996;88:1670-6.
34. Hardy RE, Eckert C, Hargreaves MK, Belay Y, Jones TN, Cebrun AJ. Breast and cervical cancer screening among low-income women: impact of a simple centralized HMO intervention. J Natl Med Assoc, 1996;88:381-4.
35. Kemohan EE. Evaluation of a pilot study for breast and cervical cancer screening with Bradford's minority ethnic women; a community development approach, 1991-93. Br J Cancer Suppl, 1996;29:S42-6.
36. Buehler SK, Parsons WL. Effectiveness of a call/recall system in improving compliance with cervical cancer screening: a randomized controlled trial. Can Med Assoc J, 1997;157:521-6.
37. Campbell E, Peterkin D, Abbott R, Rogers J. Encouraging underscreened women to have cervical cancer screening: the effectiveness of a computer strategy. Prev Med, 1997;26:801-7.
38. Margolis KL, Lurie N, McGovern PG, Tyrrell M, Slater JS. Increasing breast and cervical cancer screening in low-income women. J Gen Intern Med, 1998;13:515-21.
39. Paskett ED, McMahon K, Tatum C, et al. Clinic-based interventions to promote breast and cervical cancer screening. Prev Med, 1998;27:120-8.
40. Fernandez ME, DeBor M, Candreia MJ, Wagner AK, Stewart KR. Evaluation of ENCOREplus. A community-based breast and cervical cancer screening program. Am J Prev Med, 1999;16:35-49.
41. Paskett ED, Tatum CM, D'Agostino R Jr, et al. Community-based interventions to improve breast and cervical cancer screening: results of the Forsyth County Cancer Screening (FoCaS) Project. Cancer Epidemiol Biomarkers & Prev, 1999;8:453-9.
42. Hiatt RA, Pasick RJ, Stewart S, et al. Community-based cancer screening for underserved women: design and baseline findings from the Breast and Cervical Cancer Intervention Study. Prev Med, 2001;33:190-203.
43. Taylor VM, Hislop TG, Jackson JC, et al. A randomized controlled trial of interventions to promote cervical cancer screening among Chinese women in North America. J Natl Cancer Inst, 2002;94:670-7.
44. Valanis BG, Glasgow RE, Mullooly J, et al. Screening HMO women overdue for both mammograms and Pap tests. Prev Med, 2002;34:40-50.
45. Gustafsson L, Sparen P, Gustafsson M, Wilander E, Bergstrom R, Adami HO. Efficiency of organized and opportunistic cytological screening for cancer in situ of the cervix. Br J Cancer, 1995;72:498-505.
46. Tseng DS, Cox E, Plane MB, Hla KM. Efficacy of patient letter reminders on cervical cancer screening: a meta-analysis. J Gen Intern Med, 2001;16:563-8.
47. Taplin SH, Barlow WE, Ludman E, et al. Testing reminder and motivational telephone calls to increase screening mammography: a randomized study. J Natl Cancer Inst, 2000;92:233-42.